Seventy consenting adult patients ( seropositive for IgM/IgG anti-CHIK antibody ) with early persistent musculoskeletal pain and arthritis were randomized into a @-week , @-arm , parallel efficacy trial of CQ ( @ mg/day ) and meloxicam ( @ mg/day ) .